Publication activity
Publication activity is a key indicator of the productivity and effectiveness of the scientific work of researchers, organizations, and higher educational institutions.
Indicators of scientific productivity and efficiency of scientific activity: the number of publications and references to these publications (citation).
The high level of scientific potential of scientists of the Volga Research Medical University is confirmed by the recognition of their achievements by the domestic and foreign scientific community.
According to the international databases of scientific citation for 2017-2022
1421
The number of publications in publications indexed in Scopus
63
The Hirsch Index (h-index) of Scopus
According to the national database of scientific citation "Russian Science Citation Index"
(RSCI, elibrary.ru ) for 2017-2022
10 069
Total number of publications
23 061
Number of citations
112
The h-index (h-index)
Among all 760universities of the Russian Federation
145
by the number of scientific publications (over the last 5 years)
82
by the number of citations (accumulated total)
Among 2237 organizations of the Russian Federation with publications in the RSCI (elibrary)
154
by the number of scientific publications (over the last 5 years)
96
by the number of citations (accumulated total)
Top 10 publications for 5 years (2016-2020) by the number of citations
-
Chronic heart failure (CHF)
Mareev V.YU., Fomin I.V., Ageev F.T., Arutyunov G.P., Begrambekova YU.L., Belenkov YU.N., Vasyuk YU.A., Galyavich A.S., Garganeeva A.A., Gendlin G.E., Gilyarevskij S.R., Glezer M.G., Drapkina O.M., Duplyakov D.V., Kobalava ZH.D., Koziolova N.A., Lopatin YU.M., Mareev YU.V., Moiseev V.S., Nedoshivin A.O. i dr.
Journal of Heart Failure
2017. Т. 18. № 1 (100). С. 3-40
-
Dapagliflozin and cardiovascular outcomes in type 2 diabetes
Wiviott S.D., Raz I., Bonaca M.P., Mosenzon O., Kato E.T., Cahn A., Silverman M.G., Zelniker T.A., Kuder J.F., Murphy S.A., Bhatt D.L., Leiter L.A., McGuire D.K., Wilding J.P.H., Ruff C.T., Nilsson G.I., Fredriksson M., Johansson P.A., Langkilde A.M., Sabatine M.S. et al.
New England Journal of Medicine
2019. Т. 380. № 4. С. 347-357
-
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (keynote-040): a randomised, open-label, phase 3 study
Cohen E.E.W., Soulières D., Le Tourneau C., Dinis J., Licitra L., Ahn M.J., Soria A., Machiels J.P., Mach N., Mehra R., Burtness B., Zhang P., Cheng J., Swaby R.F., Harrington K.J., Acosta-Rivera M., Adkins D.R., Aghmesheh M., Airoldi M., Aleknavicius E. et al.
The Lancet
2019. Т. 393. № 10167. С. 156-167
-
Chronic heart failure (CHF)
Mareev V.YU., Fomin I.V., Ageev F.T., Arutyunov G.P., Begrambekova YU.L., Belenkov YU.N., Vasyuk YU.A., Galyavich A.S., Garganeeva A.A., Gendlin G.E., Gilyarevskij S.R., Glezer M.G., Drapkina O.M., Duplyakov D.V., Kobalava ZH.D., Koziolova N.A., Lopatin YU.M., Mareev YU.V., Moiseev V.S., Nedoshivin A.O. i dr.
Journal of Heart Failure
2017. Т. 18. № 1 (100). С. 3-40
-
Dapagliflozin and cardiovascular outcomes in type 2 diabetes
Wiviott S.D., Raz I., Bonaca M.P., Mosenzon O., Kato E.T., Cahn A., Silverman M.G., Zelniker T.A., Kuder J.F., Murphy S.A., Bhatt D.L., Leiter L.A., McGuire D.K., Wilding J.P.H., Ruff C.T., Nilsson G.I., Fredriksson M., Johansson P.A., Langkilde A.M., Sabatine M.S. et al.
New England Journal of Medicine
2019. Т. 380. № 4. С. 347-357
-
Prevention, diagnosis and treatment of new coronavirus infection (covid-19)
Avdeev S.N., Adamyan L.V., Alekseeva E.I., Bagnenko S.F., Baranov A.A., Baranova N.N., Belevskij A.S., Belkin A.A., Beloborodov V.B., Bodrova R.A., Bujlova T.V., Bojko E.A., Briko N.I., Brusina E.B., Vavilova T.V., Vasil'eva E.YU., Vasil'eva I.A., Veselova E.I., Vishneva E.A., Volchkova E.V. i dr.
Temporary methodological recommendations
Moscow, 2019. Vol. 380. No. 1. pp. 11-22
-
Chronic heart failure (CHF)
Mareev V.YU., Fomin I.V., Ageev F.T., Arutyunov G.P., Begrambekova YU.L., Belenkov YU.N., Vasyuk YU.A., Galyavich A.S., Garganeeva A.A., Gendlin G.E., Gilyarevskij S.R., Glezer M.G., Drapkina O.M., Duplyakov D.V., Kobalava ZH.D., Koziolova N.A., Lopatin YU.M., Mareev YU.V., Moiseev V.S., Nedoshivin A.O. i dr.
Journal of Heart Failure
2017. Т. 18. № 1 (100). С. 3-40
-
Prevention, diagnosis and treatment of new coronavirus infection (covid-19)
Avdeev S.N., Adamyan L.V., Alekseeva E.I., Bagnenko S.F., Baranov A.A., Baranova N.N., Belevskij A.S., Belkin A.A., Beloborodov V.B., Bodrova R.A., Bujlova T.V., Bojko E.A., Briko N.I., Brusina E.B., Vavilova T.V., Vasil'eva E.YU., Vasil'eva I.A., Veselova E.I., Vishneva E.A., Volchkova E.V. i dr.
Temporary methodological recommendations
Moscow, 2019. Vol. 380. No. 1. pp. 11-22
-
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (keynote-040): a randomised, open-label, phase 3 study
Cohen E.E.W., Soulières D., Le Tourneau C., Dinis J., Licitra L., Ahn M.J., Soria A., Machiels J.P., Mach N., Mehra R., Burtness B., Zhang P., Cheng J., Swaby R.F., Harrington K.J., Acosta-Rivera M., Adkins D.R., Aghmesheh M., Airoldi M., Aleknavicius E. et al.
The Lancet
2019. Т. 393. № 10167. С. 156-167
-
Dapagliflozin and cardiovascular outcomes in type 2 diabetes
Wiviott S.D., Raz I., Bonaca M.P., Mosenzon O., Kato E.T., Cahn A., Silverman M.G., Zelniker T.A., Kuder J.F., Murphy S.A., Bhatt D.L., Leiter L.A., McGuire D.K., Wilding J.P.H., Ruff C.T., Nilsson G.I., Fredriksson M., Johansson P.A., Langkilde A.M., Sabatine M.S. et al.
New England Journal of Medicine
2019. Т. 380. № 4. С. 347-357
Subscribe to our social networks
- 00
- :
- 00
PIMU
just now
Latest University news
Stay up to date with all the news.